SEBI Registration NO.---- INA000001530 Investment in stock and commodity market are subject to market risk. Please do not trade on those tips which are not provided through SMS or messenger.

Top Stocks to be Focused for 23 March 2017

Top Stocks to be Focused for 23 March 2017

Delta Corp: The company plans to raise up to Rs 750 crore through issue of equity shares or other securities via qualified institutional placement (QIP)

Divi’s Laboratories: The pharma major on Wednesday said the US health regulator issued import alert for products made at one of its units at Visakhapatnam citing violation of manufacturing norms and refusal of inspection.

DLF: Realty major DLF said it has completed the restructuring of its joint ventures with global investment firm Blackstone-managed Ridgewood Holdings, which had invested Rs 1,481 crore in seven housing projects in 2007.

Reliance Power: A promoter firm of Reliance PowerBSE 1.27 % has sold shares worth over Rs 858 crore to a group entity. Reliance Infradevelopment offloaded a total of 18 crore shares over three days starting from March 20. The shares were sold in three tranches to Reliance Wind Turbine Installators Industries at different prices.

Hindustan Zinc: Adding a third tranche to its dividend bounty for 2016-17, Hindustan Zinc on Wednesday declared a special interim dividend of Rs 13,985 crore. Together with the Golden Jubilee dividend paid in April 2016 and an interim dividend in October 2016, the dividends paid in FY17 amount to Rs 27,157 crore, the highest by a listed Indian firm in a financial year, HZL said.

Bharti Infratel: Mobile tower company Bharti Infratel on Wednesday declared an interim dividend of Rs 12 per equity share. This is the highest dividend paid by the company so far. In 2015-16, it had paid a dividend of Rs 3 per share.

Axis Bank: Private sector lender Axis BankBSE 0.63 % on Wednesday dismissed rumours about the resignation of its CEO Shikha Sharma.

IDFC Bank: IDFC Bank plans to build a network of more than one lakh points-of-presence in the next two years to enable people in the farthest corners of the country to transact digitally, a move that comes amid the government’s digitisation drive.

Apollo Hospitals: Global brokerage house UBS maintained ‘Buy’ on Apollo HospitalsBSE 0.71 % with a target price of Rs 1,610. UBS believes market may be overreacting to stent price controls imposed. Angioplasty (with stenting) contributes around 12 per cent of Apollo’s revenues.

Bank of Baroda: State owned Bank of BarodaBSE -0.22 % said it has raised Rs 1,000 crore by issuing Basel III compliant additional tier I bonds. The bonds will bear coupon rate of 9.14 per cent. The bank issued 10,000 bonds of face value of Rs 10 lakh each.

error: Content is protected !!